Biomolecules (Mar 2020)

MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo-β-Lactamase Inhibitors

  • Zishuo Cheng,
  • Caitlyn A. Thomas,
  • Adam R. Joyner,
  • Robert L. Kimble,
  • Aidan M. Sturgill,
  • Nhu-Y Tran,
  • Maya R. Vulcan,
  • Spencer A. Klinsky,
  • Diego J. Orea,
  • Cody R. Platt,
  • Fanpu Cao,
  • Bo Li,
  • Qilin Yang,
  • Cole J. Yurkiewicz,
  • Walter Fast,
  • Michael W. Crowder

DOI
https://doi.org/10.3390/biom10030459
Journal volume & issue
Vol. 10, no. 3
p. 459

Abstract

Read online

In an effort to facilitate the discovery of new, improved inhibitors of the metallo-β-lactamases (MBLs), a new, interactive website called MBLinhibitors.com was developed. Despite considerable efforts from the science community, there are no clinical inhibitors of the MBLs, which are now produced by human pathogens. The website, MBLinhibitors.com, contains a searchable database of known MBL inhibitors, and inhibitors can be searched by chemical name, chemical formula, chemical structure, Simplified Molecular-Input Line-Entry System (SMILES) format, and by the MBL on which studies were conducted. The site will also highlight a “MBL Inhibitor of the Month”, and researchers are invited to submit compounds for this feature. Importantly, MBLinhibitors.com was designed to encourage collaboration, and researchers are invited to submit their new compounds, using the “Submit” function on the site, as well as their expertise using the “Collaboration” function. The intention is for this site to be interactive, and the site will be improved in the future as researchers use the site and suggest improvements. It is hoped that MBLinhibitors.com will serve as the one-stop site for any important information on MBL inhibitors and will aid in the discovery of a clinically useful MBL inhibitor.

Keywords